Recombinant Bovine Somatotropin vs Titanium Dioxide: which is worse?

What is Recombinant Bovine Somatotropin?

Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.

What is Titanium Dioxide?

Titanium dioxide (TiO2) is a naturally occurring white mineral used as a food colorant, whitening agent, and opacity enhancer. In food applications, it exists as nano-sized and micro-sized particles. It is one of the most widely produced industrial minerals globally, used in paints, plastics, sunscreens, and food products.

Documented risks

Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.

Titanium Dioxide: The EU banned titanium dioxide as a food additive in 2022 following EFSA's landmark 2021 safety assessment (EFSA Journal 2021;19(5):6585), which concluded that titanium dioxide 'can no longer be considered safe as a food additive.' The primary concern is genotoxicity from nanoparticles: EFSA determined it was impossible to rule out the risk of DNA damage (genotoxicity) from TiO2 nanoparticles at typical food use exposure levels. In vitro studies have demonstrated that TiO2 nanoparticles cause DNA strand breaks in intestinal epithelial cells and induce oxidative stress. A 2019 study in Nature Communications found TiO2 nanoparticles could disrupt gut microbiome balance and intestinal barrier function in mice models. Multiple studies have suggested effects on gut permeability and immune function. IARC classifies titanium dioxide as Group 2B (possible human carcinogen) for inhalation exposure in occupational settings — primarily relevant to workers handling TiO2 dust, based on rat lung cancer studies. While inhalation and oral exposure are different routes, EFSA determined that the genotoxicity concerns from nanoparticles applied to oral food use as well. Following the EU ban, California attempted to pass legislation banning TiO2 in candy (along with other additives) in 2022. The bill was signed in modified form. Mars reformulated EU Skittles to remove TiO2. The US FDA has not announced specific action on food-grade TiO2 as of 2025, though USRTK and other organizations are calling for a US ban.